Chevron Left
返回到 药物开发

学生对 加州大学圣地亚哥分校 提供的 药物开发 的评价和反馈

4.7
2,079 个评分

课程概述

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

热门审阅

HG

Oct 15, 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

KR

May 24, 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

筛选依据:

1 - 药物开发 的 25 个评论(共 414 个)

创建者 Ekaterine B

Feb 20, 2018

创建者 Cynthia V

Jan 28, 2020

创建者 shaurya b

Jan 23, 2019

创建者 Humberto M

Feb 26, 2018

创建者 Dr.V.Padmavathi

Jul 4, 2020

创建者 Miriam C

May 8, 2019

创建者 Jesse G

Jan 18, 2021

创建者 Philip R

Dec 2, 2018

创建者 Adrián P F

Nov 12, 2018

创建者 Emily K

Jan 23, 2020

创建者 Dr. H R

Aug 29, 2018

创建者 Michael D

Sep 2, 2018

创建者 ANTONIOS M N C

Jun 3, 2018

创建者 HASAN B

Mar 8, 2020

创建者 Heather G

Oct 16, 2018

创建者 Shyam P

Sep 14, 2019

创建者 Giridhar R G

May 2, 2020

创建者 Ahmed I I

Dec 30, 2019

创建者 Radwa A M A E

Sep 21, 2019

创建者 ABHINAV S

Apr 26, 2020

创建者 Franceska F

Jan 12, 2020

创建者 ELENA F D

Apr 29, 2020

创建者 Yurshanva K

Sep 3, 2019

创建者 Rosa E H E

Aug 7, 2019

创建者 Bhavana S

Jul 2, 2020